{"ticker": {"uuid": "9ac2419f-b67a-4911-a4b4-a681dacbccf6", "symbol": "GUD", "name": "Knight Therapeutics Inc.", "exchange": "TOR", "country": "CA", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Knight Therapeutics (TSX:GUD) Expands Latin America Specialty Pharma Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPZW1fdlVUTV9UdW9GT3l4NGxGQlk3SE1LRDlLWkc2cnBIVkdjNzFLY2dMcXozVUx2RlBvMU0zU0dwTGtuQTk3WHl4TU9rb1pyRzc4dzVjaEJuLWFYQVNFR0hqZVFLNEJkYl9QU3A5Z2czeDhkY3pVTjhMV2JvbmROaVhEaUlQMkJXZ2RGVTJrU3lxUElad3Y5VV90THdlem5iNlVpb0d1TmFsY3hLU0RETEVQdjZ3dER5bnhKVA?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-16T20:57:00+00:00", "published_display": "16 Jul 2026 20:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Going On With Knight Therapeutics Inc. Stock Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQdG5JdktvQTV5VXcwb04xdjhwd3Atc2xOUUZCNDctckRxWXQtdUpVc2N4YjNaeFVYMzI3dE43UXRWelNLUUllVUlPSjVwYTQ5YTNOdjR5MkljNW1jQ1Z1UV9LQWxzQ2pIVU9uNFZ5dkJaN0dkSUx2SDVnZHlxQkZDYzFva01uVElhTXNYOEVrSTUyX1lESHR2d1J4d1hrUDA?oc=5", "source_name": "Wealth Awesome", "published_at": "2026-07-15T14:31:45+00:00", "published_display": "15 Jul 2026 14:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics (TSX:GUD) Deepens Its LatAm Reach", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQR2gyb0FYQkI2eThrdERvYmhaQUgwZzVLMXlzbEo5aXA5T2RwSXhlMHdiMXhiWDhrRVF0dWowNTNvM3FrbGxEcUdPTk9VVUhVdHBWNjlEQm5XcFJhRm0xM1hJZmFhbXNDQzdpeVB1YmJ2T2d0S1FxdVlKb1JwcUdwbnUyZDFSaEEwYWdRQUdqRjN0QjNCT0R2bnlvQ0Q?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-14T18:26:00+00:00", "published_display": "14 Jul 2026 18:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Announces Early Warning Filing Regarding Shares of Crescita", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This analyst just upped his price target on Knight Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOd2RiM0dITVdFR1dWV09GRHNkcDFnSWdPZ2prQndzbG1EX1lqUE91cU5HU0l3d0t1WjZ3dDg5TkdHUGVnN1FvODB1c0lWSkJpZjJOOFlBNlc2TDNDUERBNHJkT25sbENBTTJaZmdCcmswYXJZNUc2b0tSYUhXQ3pvVWlGVVpQZXV6U0tWbFdDcHRMWXdZVl9TZVcwU21McVNRX0stStIBqgFBVV95cUxNazFuQjNVcmdMRGhiT3RMZjlfZUpWS1Nxd1VwVVlDZFFNNWtuVUhCaVRPdTFHNjVqLXZzQVZkT2dpYmNqelZpS3A0c25kR3p0c3FlandKX2lwVzNQSklMQmE4QXZkS2lSUUVnWjZpTkVlVFFlcHBVRVFncWdnR0VKa01IcW54TzBFTjdOSTNISnB0ekFrTXdxWm5QRndtLTFwa01aQlNTeHA3dw?oc=5", "source_name": "Cantech Letter", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics Reports First Quarter 2026 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQQy1FZmpucGlBYmtfRDY1aWJialItNGJpampqSm1vbTdhbGh2T3VRM3FHejRFU0xRYkI2YWdNTDZ3dFVKSTNMMDY3TlEyV3NETXlWeVNFU1RRZEFEUHRxbnh6NTkyQmxMQWJNOXlHcWxNYUZRZWhhOUdVTWswbGNFUENoSUNCSU5HN01KbHVKQ0lJNkxOTjFpTENDRU9DRE1Jb2U0dUpraEIwVHFVc3g5TWItYWl0SVZTV3RIVGZzckJIbW9U?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics Number of Employees 2026 | Employee Count & Headcount Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE93VGlwQng5TkNZeFZXczltSlpoVnVtQlA4NmhKZ2hKOEFjTkZ4ZW0yLWxZbS0zLV9yQVdhLUhKYldXd2pPRFR3eEt2WmFqclRHNUJFbXB2NVBlV0hMZDlIcHBpMDRhMlpidjkwTzFSN1N1WjBvVGhZ?oc=5", "source_name": "Revelio Labs", "published_at": "2026-05-06T07:15:36+00:00", "published_display": "06 May 2026 07:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics Inc. ranks on The Globe and Mail\u2019s second annual Canada\u2019s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPT1AtMDZob2NfN1dMRW1Zb1ZCbDY3Z0ZhS0xXeWo3Z2xWUXlQMXlMWldMMVVQQWN0d0Q3bDBoODFkWF81VnBGeTVabU9ONUNpUU5xUTcwYmh0cHlKanFydGFQeGp2NHhGQkhEWTI3UE9BMm1zR1dDMlgxWjBSWHFKWVl4aFpGeS1TUWtRZlBySmU1RnV6X3NkdWVYZmlPV1g5SG5EVE9OOA?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TSX Value Picks Knight Therapeutics And 2 Other Stocks Estimated Below Intrinsic Value", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Amends Normal Course Issuer Bid", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This analyst just raised his price target on Knight Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNVDJwVDZxYmVNMzJpVEFPdkJaT3QzVmdpd3UzVi0tSzJHN1RRelZlUURmallxZDFERjJSUmtwZUxaWHdOYjdDLWFfemt4WlRESURLNDJ5VHA4MF9CZllDelJrWTM2b1Z6akNJMnV5dXR4QURwY0VnX1Zybk82Vm5KSWRSUElOWFI3YzlVYmpUMEdZZWViYlhYWFYxQURfd1hPQlV3WFhR0gGrAUFVX3lxTFB0MmFZeEg5TFBaWTJib3hjU2U0elYwTV9HT3FTemRRN3MtMWxNQUFUNzQ0NzBXSTNTN1ZuVnMzRnRmTFNOME9tQURqcW8wckJHLURNc0FDTlA1azYtZVQ0NWpxZzlSN2psWEVBZ0MxR0NQRXlQeXhDeTdwYk5RaUFCczYtd2MyOW1Mc1VTci1nYXpTcm4wUXFZUGRyNWM3U05PT0RxdDhnT1pKQQ?oc=5", "source_name": "Cantech Letter", "published_at": "2026-03-22T07:00:00+00:00", "published_display": "22 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics Q4 Profit Tests Bullish Earnings Narrative After Yearlong Loss", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxQY3VDWHV4MndBeGlCT05PU0JBM1A2bFNndnlQMnBUdjRXU2piSWFhaHJFNlB5LWdpSHdENEV4WEtsQl9iUElIT01TLWJQYXRvTUE3Y0dMWmJmZnVMOE5aZk1STUcwblk2V0tyN0dfYVg5QXBqdjIxaUNuSzNPTW1VTndVX21iRGJFc3h4SGJybUl3N3o1d3ZhdkoyeU1tcWFEZmtuSW96U0RvVHRxM2ZCeDJfYkREd19qOG9aaDNSR2lTUW1RUzJaNzRCZWV0UWt0c1J3RE1hQVNVMnJaMGxKREVyYjczTDRvcmJDNNIB8gFBVV95cUxPM0g1LXNNbnFIZGZOVlBWRE1QRjdONFF3VlUtbVZsMFhVYnM1OFF1cUJHclI1a2tIZDlNTlhBdUtHcHgwd0RwOWhjWVU1eWxTUm8yRGhfQnR1NVVUMmhkOWNBZUdIWVRIazYxNmRWQUU0YkhkWmtrbkltSWtEVWt1eXBnQWFSZDZMVkRHNXJ5UEswU01TV0hHbEw0czNaREFobzI2NlVGNTBwOHNhd1ZUTUZRUl9GZGpFTnBDY0NUUi1TTVlTRllsYklqWUplcEhWMDlwSnY5UlhSS21JckRHZHJfdGVNTEVhNzAwMlFWVW1LZw?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics is a buy, Stifel says", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOaDliWmF2cUFuM0JUT1hrS084MlVUcVhsNHVJNHd2anI2QS15eTAzTmdhTWI2aW1yQ3oxUm5KazJJX0tGZVBxTXNoYldNOTNqZGtvdkdzaElGMGJKLThYWGl6eWQ2VzUydWFGQmRxaGcxMUNvSzdUVmUySjdFc2tYM1NndUVMQdIBiwFBVV95cUxPUEJHYzJiOGZLc2RRRUhUSFAyaTZDY1pTczVLY1dLVFJGZGx1aE5zZEdxVjZuUUJ4TElkZjN5anR5bnlWeUt5cGJzY2g3RDZoa2xRNE9jdGFMdGVmeXFhTldfdjRoeFRlcUV0WjhGVFlVbjFaRC1Na0h5MWctRzJ5cW9KUmJvcmJZR18w?oc=5", "source_name": "Cantech Letter", "published_at": "2025-05-09T07:00:00+00:00", "published_display": "09 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics to buy Paladin Pharma in bid to build out Canadian business", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQVEZyYXFJZVU5RzVYQThxenMxWWszNVdKZmJJR0dxQzNYbEFwT0ZoZ0p0bkVGU3JwRW92WDI4elhqZDVxanVuYzhlamRFZEU4emM3eThLNVJURjgwSXZzWUFvOUxrcHN6N3pPbUg0dTVsbl9wZE94dWw5Q2VSRmJHSG5rbWM1R2dWQm1feFZGRnVndEFjS194bnctZEltd251SnpiQTJlME5DU2dsNDl5RlhzNU0wM0MzT1M3Vg?oc=5", "source_name": "The Globe and Mail", "published_at": "2025-03-11T07:00:00+00:00", "published_display": "11 Mar 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GUD.CA News | KNIGHT THERAPEUTICS INC (TSX:GUD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE1KQjRDSzFPNXJMWXlEZ2I2Q1dWclY2OF9Nd1MtdXZlaHZzaVFLeWYtZnVVQi00eVhSRmRLSFR1RzljZkQ4a3J4T1h2aV90dnhwRWtzaThIN3BKaTM2QXc?oc=5", "source_name": "ChartMill", "published_at": "2020-01-04T17:48:58+00:00", "published_display": "04 Jan 2020 17:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics buys Latin American drug firm for $418-million in first major acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNejNteU9zd2xTeHRndzkxb2lmdElhQzRSaEpEblRLbTRUdHNMbnQ3b0oxS0U4MUdBcjg4X2ZMZVIyRUdwZmlkVGdhR2RtbW00N1BTVDVYeTVnSUROMW9oS1E3dE5vS1k5bl95VFJHUnVTejhVaTB0SFdqWlN1VWhiSEFYeU1ESmRqd2dvQnEtRXBzM05OR0ZhemlsNnFQaWQ4X0Vka1plREF0ekxRX1JLQmowVXBvaUl4UUE?oc=5", "source_name": "The Globe and Mail", "published_at": "2019-10-21T07:00:00+00:00", "published_display": "21 Oct 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics (GUD) Stock Price, News & Analysis $GUD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE5VdzRrSzJFX2VRVVdJVlpQYlo5RzFVU3VQeUx1bWZhYXRmcFhaTG1nMi1UbnhTQThvR1Z1YzRNd2UzbXBRcWNyRlJ5V1IwblJBZWVVaw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-12T11:14:27+00:00", "published_display": "12 Aug 2016 11:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Knight Therapeutics (TSX:GUD) Expands Latin America Specialty Pharma Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPZW1fdlVUTV9UdW9GT3l4NGxGQlk3SE1LRDlLWkc2cnBIVkdjNzFLY2dMcXozVUx2RlBvMU0zU0dwTGtuQTk3WHl4TU9rb1pyRzc4dzVjaEJuLWFYQVNFR0hqZVFLNEJkYl9QU3A5Z2czeDhkY3pVTjhMV2JvbmROaVhEaUlQMkJXZ2RGVTJrU3lxUElad3Y5VV90THdlem5iNlVpb0d1TmFsY3hLU0RETEVQdjZ3dER5bnhKVA?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-16T20:57:00+00:00", "published_display": "16 Jul 2026 20:57", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Going On With Knight Therapeutics Inc. Stock Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQdG5JdktvQTV5VXcwb04xdjhwd3Atc2xOUUZCNDctckRxWXQtdUpVc2N4YjNaeFVYMzI3dE43UXRWelNLUUllVUlPSjVwYTQ5YTNOdjR5MkljNW1jQ1Z1UV9LQWxzQ2pIVU9uNFZ5dkJaN0dkSUx2SDVnZHlxQkZDYzFva01uVElhTXNYOEVrSTUyX1lESHR2d1J4d1hrUDA?oc=5", "source_name": "Wealth Awesome", "published_at": "2026-07-15T14:31:45+00:00", "published_display": "15 Jul 2026 14:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics (TSX:GUD) Deepens Its LatAm Reach", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQR2gyb0FYQkI2eThrdERvYmhaQUgwZzVLMXlzbEo5aXA5T2RwSXhlMHdiMXhiWDhrRVF0dWowNTNvM3FrbGxEcUdPTk9VVUhVdHBWNjlEQm5XcFJhRm0xM1hJZmFhbXNDQzdpeVB1YmJ2T2d0S1FxdVlKb1JwcUdwbnUyZDFSaEEwYWdRQUdqRjN0QjNCT0R2bnlvQ0Q?oc=5", "source_name": "Kalkine Media", "published_at": "2026-07-14T18:26:00+00:00", "published_display": "14 Jul 2026 18:26", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Announces Early Warning Filing Regarding Shares of Crescita", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-06-06T07:00:00+00:00", "published_display": "06 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This analyst just upped his price target on Knight Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOd2RiM0dITVdFR1dWV09GRHNkcDFnSWdPZ2prQndzbG1EX1lqUE91cU5HU0l3d0t1WjZ3dDg5TkdHUGVnN1FvODB1c0lWSkJpZjJOOFlBNlc2TDNDUERBNHJkT25sbENBTTJaZmdCcmswYXJZNUc2b0tSYUhXQ3pvVWlGVVpQZXV6U0tWbFdDcHRMWXdZVl9TZVcwU21McVNRX0stStIBqgFBVV95cUxNazFuQjNVcmdMRGhiT3RMZjlfZUpWS1Nxd1VwVVlDZFFNNWtuVUhCaVRPdTFHNjVqLXZzQVZkT2dpYmNqelZpS3A0c25kR3p0c3FlandKX2lwVzNQSklMQmE4QXZkS2lSUUVnWjZpTkVlVFFlcHBVRVFncWdnR0VKa01IcW54TzBFTjdOSTNISnB0ekFrTXdxWm5QRndtLTFwa01aQlNTeHA3dw?oc=5", "source_name": "Cantech Letter", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics Reports First Quarter 2026 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQQy1FZmpucGlBYmtfRDY1aWJialItNGJpampqSm1vbTdhbGh2T3VRM3FHejRFU0xRYkI2YWdNTDZ3dFVKSTNMMDY3TlEyV3NETXlWeVNFU1RRZEFEUHRxbnh6NTkyQmxMQWJNOXlHcWxNYUZRZWhhOUdVTWswbGNFUENoSUNCSU5HN01KbHVKQ0lJNkxOTjFpTENDRU9DRE1Jb2U0dUpraEIwVHFVc3g5TWItYWl0SVZTV3RIVGZzckJIbW9U?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics Number of Employees 2026 | Employee Count & Headcount Data", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE93VGlwQng5TkNZeFZXczltSlpoVnVtQlA4NmhKZ2hKOEFjTkZ4ZW0yLWxZbS0zLV9yQVdhLUhKYldXd2pPRFR3eEt2WmFqclRHNUJFbXB2NVBlV0hMZDlIcHBpMDRhMlpidjkwTzFSN1N1WjBvVGhZ?oc=5", "source_name": "Revelio Labs", "published_at": "2026-05-06T07:15:36+00:00", "published_display": "06 May 2026 07:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics Inc. ranks on The Globe and Mail\u2019s second annual Canada\u2019s Top Growing Women-Led Companies and seventh annual Women Lead Here benchmark of executive gender diversity", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxPT1AtMDZob2NfN1dMRW1Zb1ZCbDY3Z0ZhS0xXeWo3Z2xWUXlQMXlMWldMMVVQQWN0d0Q3bDBoODFkWF81VnBGeTVabU9ONUNpUU5xUTcwYmh0cHlKanFydGFQeGp2NHhGQkhEWTI3UE9BMm1zR1dDMlgxWjBSWHFKWVl4aFpGeS1TUWtRZlBySmU1RnV6X3NkdWVYZmlPV1g5SG5EVE9OOA?oc=5", "source_name": "Market source", "published_at": "2026-03-27T07:00:00+00:00", "published_display": "27 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TSX Value Picks Knight Therapeutics And 2 Other Stocks Estimated Below Intrinsic Value", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Amends Normal Course Issuer Bid", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Manila Times", "published_at": "2026-03-23T07:00:00+00:00", "published_display": "23 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This analyst just raised his price target on Knight Therapeutics", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNVDJwVDZxYmVNMzJpVEFPdkJaT3QzVmdpd3UzVi0tSzJHN1RRelZlUURmallxZDFERjJSUmtwZUxaWHdOYjdDLWFfemt4WlRESURLNDJ5VHA4MF9CZllDelJrWTM2b1Z6akNJMnV5dXR4QURwY0VnX1Zybk82Vm5KSWRSUElOWFI3YzlVYmpUMEdZZWViYlhYWFYxQURfd1hPQlV3WFhR0gGrAUFVX3lxTFB0MmFZeEg5TFBaWTJib3hjU2U0elYwTV9HT3FTemRRN3MtMWxNQUFUNzQ0NzBXSTNTN1ZuVnMzRnRmTFNOME9tQURqcW8wckJHLURNc0FDTlA1azYtZVQ0NWpxZzlSN2psWEVBZ0MxR0NQRXlQeXhDeTdwYk5RaUFCczYtd2MyOW1Mc1VTci1nYXpTcm4wUXFZUGRyNWM3U05PT0RxdDhnT1pKQQ?oc=5", "source_name": "Cantech Letter", "published_at": "2026-03-22T07:00:00+00:00", "published_display": "22 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics Q4 Profit Tests Bullish Earnings Narrative After Yearlong Loss", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-20T07:00:00+00:00", "published_display": "20 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics is a buy, Stifel says", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxOaDliWmF2cUFuM0JUT1hrS084MlVUcVhsNHVJNHd2anI2QS15eTAzTmdhTWI2aW1yQ3oxUm5KazJJX0tGZVBxTXNoYldNOTNqZGtvdkdzaElGMGJKLThYWGl6eWQ2VzUydWFGQmRxaGcxMUNvSzdUVmUySjdFc2tYM1NndUVMQdIBiwFBVV95cUxPUEJHYzJiOGZLc2RRRUhUSFAyaTZDY1pTczVLY1dLVFJGZGx1aE5zZEdxVjZuUUJ4TElkZjN5anR5bnlWeUt5cGJzY2g3RDZoa2xRNE9jdGFMdGVmeXFhTldfdjRoeFRlcUV0WjhGVFlVbjFaRC1Na0h5MWctRzJ5cW9KUmJvcmJZR18w?oc=5", "source_name": "Cantech Letter", "published_at": "2025-05-09T07:00:00+00:00", "published_display": "09 May 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics to buy Paladin Pharma in bid to build out Canadian business", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQVEZyYXFJZVU5RzVYQThxenMxWWszNVdKZmJJR0dxQzNYbEFwT0ZoZ0p0bkVGU3JwRW92WDI4elhqZDVxanVuYzhlamRFZEU4emM3eThLNVJURjgwSXZzWUFvOUxrcHN6N3pPbUg0dTVsbl9wZE94dWw5Q2VSRmJHSG5rbWM1R2dWQm1feFZGRnVndEFjS194bnctZEltd251SnpiQTJlME5DU2dsNDl5RlhzNU0wM0MzT1M3Vg?oc=5", "source_name": "The Globe and Mail", "published_at": "2025-03-11T07:00:00+00:00", "published_display": "11 Mar 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GUD.CA News | KNIGHT THERAPEUTICS INC (TSX:GUD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiXkFVX3lxTE1KQjRDSzFPNXJMWXlEZ2I2Q1dWclY2OF9Nd1MtdXZlaHZzaVFLeWYtZnVVQi00eVhSRmRLSFR1RzljZkQ4a3J4T1h2aV90dnhwRWtzaThIN3BKaTM2QXc?oc=5", "source_name": "ChartMill", "published_at": "2020-01-04T17:48:58+00:00", "published_display": "04 Jan 2020 17:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics buys Latin American drug firm for $418-million in first major acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNejNteU9zd2xTeHRndzkxb2lmdElhQzRSaEpEblRLbTRUdHNMbnQ3b0oxS0U4MUdBcjg4X2ZMZVIyRUdwZmlkVGdhR2RtbW00N1BTVDVYeTVnSUROMW9oS1E3dE5vS1k5bl95VFJHUnVTejhVaTB0SFdqWlN1VWhiSEFYeU1ESmRqd2dvQnEtRXBzM05OR0ZhemlsNnFQaWQ4X0Vka1plREF0ekxRX1JLQmowVXBvaUl4UUE?oc=5", "source_name": "The Globe and Mail", "published_at": "2019-10-21T07:00:00+00:00", "published_display": "21 Oct 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Knight Therapeutics (GUD) Stock Price, News & Analysis $GUD", "summary": "", "url": "https://news.google.com/rss/articles/CBMiVEFVX3lxTE5VdzRrSzJFX2VRVVdJVlpQYlo5RzFVU3VQeUx1bWZhYXRmcFhaTG1nMi1UbnhTQThvR1Z1YzRNd2UzbXBRcWNyRlJ5V1IwblJBZWVVaw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-12T11:14:27+00:00", "published_display": "12 Aug 2016 11:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 64, "total_relevant": 17, "sentiment_summary": {"positive": 4, "negative": 1, "neutral": 12, "score": 54, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 85, "events": [{"event": "general", "label": "Market update", "weight": 6.6, "count": 12}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 9.8, "latest_week": "2026-07-10", "one_week_move": -1.1, "four_week_move": 3.4, "twelve_week_move": 28.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.290009, "market_dynamics_buy_signal": false, "relative_strength": 29.782226, "fair_value_gap": 65.6, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 47.9276, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.1% over one week, +3.4% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Cantech Letter", "count": 3}, {"label": "Kalkine Media", "count": 2}, {"label": "The Manila Times", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "The Globe and Mail", "count": 2}, {"label": "Wealth Awesome", "count": 1}, {"label": "GlobeNewswire", "count": 1}, {"label": "Revelio Labs", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Analyst action", "count": 2}, {"label": "Earnings", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "85/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.1% over one week, +3.4% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Knight Therapeutics (TSX:GUD) Expands Latin America Specialty Pharma Platform"}], "updated_at": "2026-07-17T19:50:27.964149+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}